US Patent 10272083 | Patents | Expiry | Expiration | Dates

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2685

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2682

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2687

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2684

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2686

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2683

Delist Requested

Application Number

210259

Patent Use Description

Product Number

1

ASTRAZENECA

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United Kingdom Flag United Kingdom

Post An Enquiry

Virtual Booth

ACALABRUTINIB

Supporting Information : Click here to upload a PDF

US Patent Number

10272083

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2035-01-21

Patent Use Code

U-2519

Delist Requested

Application Number

210259

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10272083

2035-01-21

U-2685

1

2035-01-21

U-2682

1

2035-01-21

U-2687

1

2035-01-21

U-2684

1

2035-01-21

U-2686

1

2035-01-21

U-2683

1

2035-01-21

U-2519

1